ARCHIVES

ACS Concludes That Laetrile Organization Is Insignificant

This article is from The Cancer Letter archive.

Vol. 17 No. 46 | November 29, 1991

Download PDF Visit The Full Archive

Related Articles

House panel investigating NIH handling of tissue specimens.

June 24, 2005

Public Participation Hearings Develop Gals for Reducing Cancer Mortality

February 17, 1989

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014

Daily Aspirin May Reduce Risk By 20 Percent, Study Says

February 28, 2014

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

HHS Hearings to Form National Breast Cancer Strategy. Shalala Says

October 29, 1993